Ensysce Biosciences, Inc. (ENSC) Dividend History

Ensysce Biosciences, Inc. develops innovative drug delivery technologies aimed at improving safety and efficacy in pain management and other therapeutic areas. The company focuses on creating proprietary prodrug platforms that enhance pharmacological control and reduce abuse potential of opioids and other drugs.

7946 Ivanhoe Avenue, La Jolla, CA, 92037
Phone: (858) 263-4196
Website: https://www.ensysce.com

Dividend History

Ensysce Biosciences, Inc. currently does not pay dividends

Company News

  • Ensysce Biosciences advanced multiple clinical initiatives in Q2 2025, including launching a Phase 3 trial for PF614, completing enrollment in an overdose prevention study, and receiving a patent notice for its OUD program.

    GlobeNewswire Inc.
  • Ensysce Biosciences reported Q2 2025 results, advancing its PF614 opioid program to Phase 3 and achieving milestones in overdose-protection studies. The company reported a narrower GAAP loss of $(0.79) per share, with revenue primarily from federal grants.

    The Motley Fool
  • Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion. AMD shares dipped 3.8% to $165.49 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 204% to $0.6049. Connexa said it has regained compliance with Nasdaq minimum shareholder equity rule. Minim, Inc. (NASDAQ: MINM) shares climbed 76.4% to $4.48. David E. Lazar disclosed a 51% active stake in Minim Inc. Powell Industries, Inc. (NASDAQ: POWL) shares gained 49% to $121.89 after the company reported better-than-expected first-quarter financial results and raised its quarterly dividend. Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) climbed 46.5% to $0.1180 after falling around 7% on Tuesday. Ashford Hospitality Trust, Inc. (NYSE: AHT) jumped 32% to $1.77. 2seventy bio, Inc. (NASDAQ: TSVT) rose 31.6% to $5.28. 2seventy Bio said it will focus exclusively on commercialization and development of Abecma and sell its R&D pipeline to Regeneron. Leerink Partners analyst Daina Graybosch upgraded 2seventy bio from Market Perform to Outperform and raised the price target from $5 to $18. Trinity Biotech plc (NASDAQ: TRIB) gained 29.5% to $0.5638. Trinity Biotech announced acquisition of the CGM assets of Waveform Technologies, Inc. Kuke Music Holding Limited (NYSE: KUKE) rose 23.7% to $1.25. Vaxart, Inc. (NASDAQ: VXRT) jumped 20.9% to $1.1850. B. Riley Securities analyst Mayank Mamtani upgraded Vaxart from Neutral to Buy and announced a $2 price target. Envirotech Vehicles, Inc. (NASDAQ: EVTV) gained 20.6% to $1.75. Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 19.6% to ...

    Benzinga
  • Penny stocks to buy according to analysts. The post 4 Penny Stocks To Buy According To Analysts, Targets Up To 1,560% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: MYPS OCGN VYNE
  • Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. U.S.

    Seeking Alpha
    Featured Companies: AMZN BOLT DE JNJ K MDLZ MO MRNA PFE PM RDUS SBUX SGMA VSTA
Page data last updated 09/07/2025 04:05:45 UTC